Medical Equipment

Global Pediatric Interventional Cardiology Market Revenue and Share Analysis Through 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pediatric interventional cardiology market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Pediatric Interventional Cardiology Market In The Period 2029-2034?

The pediatric interventional cardiology market has shown strong growth in recent years. Its value is expected to rise from $2.44 billion in 2024 to $2.6 billion in 2025, at a compound annual growth rate (CAGR) of 6.3%. Historically, this expansion can be attributed to increased mycotoxin awareness, stringent regulatory standards, a focus on animal health, the globalization of poultry production, market competitiveness, and increased farm productivity.

The pediatric interventional cardiology market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $3.59 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.4%. Factors contributing to this growth during the forecast period include the expanding poultry industry, the impacts of climate change, a rising demand for organic products, global trade dynamics, governmental initiatives, and increasing health consciousness. Key trends anticipated within this period encompass the integration of technology, a focus on feed quality and safety, market consolidation, collaborative research efforts, the digitalization of agriculture, and advancements in feed technology.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10384&type=smp

What Strategic Drivers Are Accelerating The Pediatric Interventional Cardiology Market Expansion?

The rising occurrence of congenital heart disease is anticipated to boost the expansion of the pediatric interventional cardiology market. Congenital heart disease refers to any anomaly impacting the heart and its structure from birth. Procedures in pediatric interventional cardiology address congenital heart disease, offering benefits over conventional open-heart surgery, such as quicker recovery, lower infection risk, and minimal scarring. Illustratively, in 2022, the American Heart Association, a US-based non-profit organization dedicated to cardiovascular medical research, reported that approximately 40,000 infants in the United States suffer from congenital heart defects, with an estimated birth prevalence of 12.3 per 1000 in the country. Moreover, in 2022, The Lancet, a weekly peer-reviewed general medical journal from the United Kingdom, published an article indicating that congenital heart disease stands as the most frequent birth defect, impacting close to 9 out of every 1000 live births. Consequently, the growing incidence of congenital heart disease will stimulate the growth of the pediatric interventional cardiology market.

What Is The Detailed Segment Distribution Of The Pediatric Interventional Cardiology Market?

The pediatric interventional cardiologymarket covered in this report is segmented –

1) By Device Type: Closure Devices, Trans catheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Other Device Types

2) By Procedure: Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Other Procedures

3) By End-Use: Clinical Testing Laboratories, Hospitals, Cardiac Centers, Pediatric Clinics, Research Institutions

Subsegments:

1) By Closure Devices: Atrial Septal Defect (ASD) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices

2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Replacement (TAVR) Devices, Transcatheter Mitral Valve Repair Devices, Transcatheter Pulmonary Valve Replacement Devices

3) By Atherectomy Devices: Directional Atherectomy Devices, Rotational Atherectomy Devices, Laser Atherectomy Devices

4) By Catheters: Diagnostic Catheters, Therapeutic Catheters, Guiding Catheters

5) By Balloons: Balloon Angioplasty Balloons, Intra-Aortic Balloons, High-Pressure Balloons

6) By Stents: Drug-Eluting Stents, Bare-Metal Stents, Bioresorbable Stents

7) By Other Device Types: Vascular Closure Devices, Hemodynamic Monitoring Devices, Electrophysiology Devices

How Are Global Trends Impacting The Development Of The Pediatric Interventional Cardiology Market?

Product innovation stands out as a key trend within the pediatric interventional cardiology market. Major companies operating in pediatric interventional cardiology are introducing new and advanced solutions to reinforce their market presence. For instance, in February 2023, Medtronic plc., a US-based medical devices company, launched the Harmony Transcatheter Pulmonary Valve System, a transcatheter pulmonary valve. The Harmony TPV system offers a minimally invasive alternative to open-heart surgery and can be implanted through a small incision in the leg or neck. This system is designed for patients who have previously undergone surgery for congenital heart disease and possess a dysfunctional RVOT (right ventricular outflow tract) due to an earlier implanted conduit or bioprosthetic pulmonary valve. It is also indicated for patients with native or patched RVOT who require pulmonary valve replacement.

Who Are The Major Stakeholders Operating In The Pediatric Interventional Cardiology Market?

Major companies operating in the pediatric interventional cardiology market include Medtronic plc, GE HealthCare Technologies Inc., Abbott Laboratories, Terumo Corporation, W.L. Gore & Associates Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Siemens Healthineers, Numed Inc., St. Jude Medical Inc., Cordis Corporation, Koninklijke Philips N.V., Biotronik, B. Braun Melsungen AG, Canon Medical Systems Corporation, Gore & Associates Inc., Johnson and Johnson, Cook Group LLC, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Lepu Medical Technology (Beijing) Co.Ltd., Biosensors International Group Ltd., Cardiac Science Corporation, Asahi Intecc Co.Ltd., Medinol Ltd., Jotec GmbH, Hexacath Ltd., Translumina GmbH

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pediatric-interventional-cardiology-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Pediatric Interventional Cardiology Market?

North America was the largest region in the pediatric interventional cardiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global pediatric interventional cardiology market during the forecast period. The regions covered in the pediatric interventional cardiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10384&type=smp

Browse Through More Reports Similar to the Global Pediatric Interventional Cardiology Market 2025, By The Business Research Company

Pediatric Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Pediatric Dental Crown Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-dental-crown-global-market-report

Pediatric Imaging Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-imaging-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795